Stryker Corporation  

(Public, NYSE:SYK)   Watch this stock  
Find more results for Rounder, Inc
80.48
+0.39 (0.49%)
Real-time:   10:57AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 79.94 - 80.52
52 week 66.44 - 86.93
Open 80.14
Vol / Avg. 169,907.00/1.37M
Mkt cap 30.42B
P/E 44.78
Div/yield 0.31/1.52
EPS 1.80
Shares 378.00M
Beta 0.90
Inst. own 73%
Oct 16, 2014
Q3 2014 Stryker Earnings Release (Estimated) Add to calendar
Sep 17, 2014
Stryker Corp Analyst Meeting - 2:30PM EDT - Add to calendar
Jul 17, 2014
Q2 2014 Stryker Earnings Conference Call - Webcast
Jul 17, 2014
Q2 2014 Stryker Earnings Release
Jun 18, 2014
Stryker at Wells Fargo Healthcare Conference - Webcast
Jun 10, 2014
Stryker at Goldman Sachs Healthcare Conference - Webcast
Jun 2, 2014
Stryker at Jefferies Global Healthcare Conference
May 13, 2014
Stryker at Bank of America Merrill Lynch Health Care Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 5.42% 11.15%
Operating margin 8.34% 13.92%
EBITD margin - 25.77%
Return on average assets 3.08% 6.95%
Return on average equity 5.68% 11.40%
Employees 25,000 -
CDP Score - 53 E

Address

2825 Airview Boulevard
KALAMAZOO, MI 49002
United States - Map
+1-269-3852600 (Phone)
+1-269-3851062 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Stryker Corporation (Stryker) is a medical technology company. Stryker offers a diverse array of medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. The Company operates in three business segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Its products include implants used in joint replacement, trauma, and spinal surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment, as well as other medical device products used in a variety of medical specialties. In the United States, its products are marketed directly to doctors, hospitals and other health-care facilities. Internationally, its products are sold in over 100 countries through Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. In April 2014, the Company acquired Berchtold Holding AG.

Officers and directors

Kevin A. Lobo Chairman of the Board, President, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
William R. Jellison Chief Financial Officer, Vice President
Age: 56
Bio & Compensation  - Reuters
Lonny J. Carpenter Group President - Global Quality and Operations
Age: 52
Bio & Compensation  - Reuters
David K. Floyd Group President - Orthopaedics
Age: 53
Bio & Compensation  - Reuters
Timothy J. Scannell Group President - MedSurg and Neurotechnology
Age: 49
Bio & Compensation  - Reuters
Ramesh Subrahmanian Group President - International
Age: 52
Bio & Compensation  - Reuters
Scott P. Bruder M.D., Ph.D. Vice President, Chief Medical and Scientific Officer
Age: 51
Bio & Compensation  - Reuters
Steven P. Benscoter Vice President - Human Resources
Age: 46
Bio & Compensation  - Reuters
Katherine Ann Owen Vice President - Strategy and Investor Relations
Age: 43
Bio & Compensation  - Reuters
Dean H. Bergy Vice President, Corporate Secretary
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance